ValedaTM PBM is the first and only FDA-authorized treatment for dry AMD to improve and maintain vision for up to 2 years
Retina Specialists of Minnesota is the first retina specialist in Minnesota to offer Valeda treatment to patients with dry AMD.
Stages of dry AMD
Dry AMD can get worse without treatment, eventually leading to permanent vision loss.
Early
Presence of small or medium-sized yellow or white spots on the back of one or both eyes.
Intermediate
Presence of many medium-sized spots or a large spot.
Advanced (geographic atrophy)
Eye tissue slowly wears away, which leads to loss of vision.
Valeda™ PBM LIGHTSITE III clinical trial met the predetermined primary efficacy endpoint at Month 21
84% of Valeda™ PBM–treated patients improved or maintained vision at ~2 years compared to baseline
More than 60% of Valeda™ PBM–treated patients experienced ≥1-line vision improvement at about 2 years compared to baseline
Just 3 Treatments each week for 3 weeks!
Treatments can fit into your daily life.
Treatments are given here at the office with Dr. Montezuma. It may take up to 10 minutes or less to complete.
​
​
Valeda PBM is non-invasive, which means there are no needles; only light us used.
​
Your pupils are not dilated, and there is no anesthesia. This means you are free to carry on with your daily activities after treatment.
​
​
LIGHTSITE IIIB Extends PBM Evidence in Dry AMD
https://www.retinalphysician.com/issues/2025/julyaugust/asrs15/